Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 3Breast 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 9481Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glucose Intolerance × Breast × Clear all
NCT05038137 2026-06-02

TREC

Medical University of South Carolina

Phase NA Completed
29 enrolled 16 charts
Breast

Intermittent Fasting, Breast Neoplasms, Glucose Intolerance

NCT04210128 2023-11-01

Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment

Memorial Sloan Kettering Cancer Center

Completed
3 enrolled
BreastGastrointestinal

Breast Neoplasms, Diabetes Mellitus, Pancreatic Neoplasms, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡